Answers are grounded in this paper and cite their sources.
Trial evaluates rapid antimicrobial susceptibility testing impacts on clinical outcomes in bloodstream infections, indicating potential benefits.
This trial evaluated whether rapid antimicrobial susceptibility testing (AST) for bloodstream infections (BSIs) caused by gram-negative bacilli (GNB) led to improved clinical outcomes compared with standard testing in regions with high antimicrobial resistance.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: